Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1280 participants
INTERVENTIONAL
2004-01-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
education, counselling, default tracer
education,counseling, default tracers,quality of care
these interventions were administered along with standard treatment i.e. DOTS at the time of standard follow up of patients at clinic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
education,counseling, default tracers,quality of care
these interventions were administered along with standard treatment i.e. DOTS at the time of standard follow up of patients at clinic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18years
* either sex
* diagnosed to have tuberculosis through chest x ray or sputum microscopy
* eligible to participate in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gambat Institute of Medical Sciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maliha Naseer
senior resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nisar Sheikh, MBBS
Role: PRINCIPAL_INVESTIGATOR
GIMS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Basic Medical Unit of Taluka Gambat
Khairpur, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TB
Identifier Type: -
Identifier Source: org_study_id